Inflammation, Molecular imaging, PET-CT, Nuclear medicine conventional, Arteries / Aorta
V. Bonello , S. Zafar, N. Khan, L. Dennis, M. Pelly, F. A. Kazmi; LONDON/UK
18F-FDG PET should be considered as a non-invasive imaging modality in patients presenting with a combination of non-specific systemic symptoms,
elevated inflammatory markers and unremarkable findings on conventional cross-sectional imaging with a clinical suspicion of LVV.
Studies have indicated that this modality shows an overall good sensitivity and specificity in the diagnosis of LVV,
expediting diagnosis and assessing disease extent prior to the development of complications.
Further studies using standardised image acquisition and interpretation are required to consolidate these findings and to establish the role of PET in monitoring treatment response and disease progression.